[Current status of brain edema therapy].
D000208:Acute Disease; D000700:Analgesics / Q000627:therapeutic use; D001929:Brain Edema / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002245:Carbon Dioxide / Q000378:metabolism; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D006985:Hyperventilation / Q000209:etiology; D007036:Hypothermia, Induced; D007040:Hypoventilation / Q000209:etiology; D007427:Intracranial Pressure; D008353:Mannitol / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010313:Partial Pressure; D012122:Ventilators, Mechanical
D000700:Analgesics; D004876:Ergot Alkaloids; D005938:Glucocorticoids; D002245:Carbon Dioxide; D008353:Mannitol; D005665:Furosemide
Derzeitiger Stand der Therapie des Hirnödems